PBS restrictions placed on diabetes medicines GPs now need to gain additional approval prior to starting patients on all GLP-1 RAs, including semaglutide.
Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
Pharmacy raided in Ozempic crackdown A large quantity of semaglutide was seized from a Melbourne chemist as part of a TGA probe into alleged manufacturing of copycat drugs.
GP concern over new Ozempic copycat Telehealth start-up Eucalyptus will soon start selling compounded semaglutide, amid a worldwide shortage of the viral drug.
Semaglutide shortage sparks patient demands for alternatives But in Australia, the new drug generating the most interest is still in its infancy – and not yet listed on the PBS.
Viral weight loss drug linked to pancreatitis Semaglutide could be putting patients at greater risk of severe gastrointestinal complications when used for obesity management.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
Telehealth provider defies TGA semaglutide request Eucalyptus is reportedly offering patients access to the type 2 diabetes-indicated drug for weight loss purposes, despite ongoing supply issues.
Warning over fake semaglutide Counterfeit products are being illegally imported into Australia, TGA testing has revealed.